1 |
Remdesivir |
Interventional |
Treatment |
453 |
Capital Medical University (NCT04257656) |
2 |
Remdesivir |
Interventional |
Treatment |
308 |
(Capital Medical University) NCT04252664
|
3 |
Remdesivir |
Expanded Access |
Treatment |
|
U.S. Army Medical Research and Development Command (NCT04302766) |
4 |
Remdesivir |
Interventional |
Treatment |
400 |
Gilead Sciences (NCT04292899) |
5 |
Remdesivir |
Interventional |
Treatment |
600 |
Gilead Sciences (NCT04292730) |
6 |
Remdesivir |
Expanded Access |
Treatment |
- |
Gilead Sciences (NCT04323761) |
7 |
Remdesivir |
Interventional |
Treatment |
440 |
National Institute of Allergy and Infectious Diseases (NCT04280705) |
8 |
Hydroxychloroquine |
Interventional Phase 3 |
Treatment |
440 |
Medical University of Vienna (NCT04336748) |
9 |
Hydroxychloroquine Remdesivir |
Interventional |
Treatment |
700 |
Oslo University Hospital (NCT04321616) |
10 |
Chloroquine/hydroxychloroquine |
Interventional Phase 2 |
Prevention |
55000 |
Washington University School of Medicine (NCT04333732) |
11 |
Chloroquine phosphate |
Interventional |
Treatment |
250 |
Oxford University Clinical Research Unit, Vietnam (NCT04328493) |
12 |
Chloroquine |
Interventional Phase 2, Phase 3 |
Treatment |
210 |
HaEmek Medical Center, Israel (NCT04333628) |
13 |
Chloroquine phosphate |
Interventional Phase 3 |
Treatment |
400 |
Wrocław Medical University |
|
|
|
|
|
(NCT04331600) |
14 |
Chloroquine or Hydroxychloroquine |
Interventional |
Prevention |
4000 |
University of Oxford (NCT04303507) |
15 |
Chloroquine analog, Nivolumab, Tocilizumab |
Interventional Phase 2 |
Treatment |
273 |
Centre Leon Berard (NCT04333914) |
16 |
Chloroquine Diphosphate |
Interventional Phase 2 |
Treatment |
440 |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (NCT04323527) |
17 |
Azithromycin and Chloroquine |
Interventional Phase 3 |
Treatment |
1500 |
Population Health Research Institute (NCT04324463) |
18 |
Azithromycin, Hydroxychloroquine |
Interventional Phase 4 |
Treatment |
226 |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark (NCT04322396) |
19 |
Darunavir and hydroxychloroquine |
Interventional Phase 3 |
Treatment |
3040 |
Fundacio Lluita Contra la SIDA (NCT04304053) |
20 |
Hydroxychloroquine |
Interventional Phase 3 |
Treatment |
2486 |
Gangnam Severance Hospital (NCT04330144) |
21 |
Hydroxychloroquine Sulfate |
Interventional |
Treatment |
220 |
University Hospital, Akershus (NCT04316377) |
22 |
Hydroxychloroquine azithromycin |
Interventional Phase 3 |
Treatment |
440 |
Hospital Israelita Albert Einstein (NCT04321278) |
23 |
Hydroxychloroquine |
Interventional |
Treatment |
1300 |
University Hospital, Angers (NCT04325893) |
24 |
Levamisole, Budesonide, Formoterol, Lopinavir/Ritonavir hydroxychloroquine |
Interventional Phase2 and 3 |
Treatment |
30 |
Fasa University of Medical Sciences (NCT04331470) |
25 |
Carrimycin lopinavir/ritonavir Arbidol, chloroquine phosphate |
Interventional Phase 4 |
Treatment |
520 |
Beijing YouAn Hospital (NCT04286503) |
26 |
Oseltamivir, Hydroxychloroquine LopipinavirRitonavir, Darunavir Favipiravir |
Interventional Phase 3 |
Treatment |
80 |
Rajavithi Hospital (NCT04303299) |
27 |
Favipiravir |
Interventional |
Treatment |
210 |
Peking University First Hospital (NCT04333589) |
28 |
Favipiravir |
Interventional Phase 3 |
Treatment |
100 |
Giuliano Rizzardini (NCT04336904) |
29 |
Arbidol |
Interventional Phase 4 |
Treatment |
380 |
Jieming QU (NCT04260594) |
30 |
ASC09(novel investigational protease inhibitor) lopinavir/ritonavir |
Interventional |
Treatment |
160 |
First Affiliated Hospital of Zhejiang University (NCT04261907) |
31 |
Lopinavir/ritonavir Hydroxychloroquine sulfate |
Interventional phase 2 |
Treatment |
150 |
Asan Medical Center (NCT04307693) |
32 |
Lopinavir/ritonavir |
Interventional phase 2 |
Treatment |
440 |
Sunnybrook Health Sciences Centre (NCT04330690) |
33 |
Hydroxychloroquine Lopinavir/ritonavir |
Interventional Phase 3 |
Treatment |
1200 |
Centre Hospitalier Universitaire de Saint Etienne (NCT04328285) |
34 |
Hydroxychloroquine Oseltamivir Azithromycin |
Interventional Phase 3 |
Treatment |
500 |
Shehnoor Azhar (NCT04338698) |
35 |
lopinavir/ritonavir Hydroxychloroquine Sulfate Losartan |
Interventional Phase 2,3 |
Treatment |
4000 |
Bassett Healthcare (NCT04328012) |
36 |
Abidol hydrochloride, Oseltamivir Lopinavir/ritonavir |
Interventional Phase 4 |
Treatment |
400 |
Tongji Hospital |
|
|
|
|
|
(NCT04255017) |
37 |
Lopinavir/ritonavir tablets Xiyanping injection |
Interventional |
Treatment |
80 |
Jiangxi Qingfeng Pharmaceutical Co. Ltd. (NCT04295551) |
38 |
lopinavir/ritonavir and Traditional Chinese Medicines |
Interventional |
Treatment |
150 |
Beijing 302 Hospital (NCT04251871) |
39 |
Methylprednisolone |
Interventional Phase 2 |
Treatment |
104 |
University of Trieste (NCT04323592) |
40 |
Colchicine |
Interventional Phase 3 |
Treatment |
2500 |
Estudios Clínicos Latino América (NCT04328480) |
41 |
Angiotensin 1-7 |
Interventional Phase 2/3 |
Treatment |
60 |
Erasme University Hospital(NCT04332666) |
42 |
Thalidomide |
Interventional Phase 2 |
Treatment |
40 |
First Affiliated Hospital of Wenzhou Medical University (NCT04273581) |
43 |
Thalidomide |
Interventional Phase 2 |
Treatment |
100 |
First Affiliated Hospital of Wenzhou Medical University NCT04273529
|
44 |
Dietary Supplement: Natural Honey |
Interventional Phase 3 |
Treatment |
1000 |
Misr University for Science and Technology (NCT04324489) |